Literature DB >> 31147294

The History of Estrogen Therapy.

Grace E Kohn1, Katherine M Rodriguez2, James Hotaling3, Alexander W Pastuszak4.   

Abstract

INTRODUCTION: Menopausal hormone therapy (MHT) has proven an effective treatment for the amelioration of symptoms of menopause. The idea that a substance was the missing factor in a woman's body after menopause dates to the 1800s, when cow ovarian tissue was injected into German women in a successful attempt to reverse the sexual symptoms of menopause. The early 1900s saw the rise of commercialized menopause "treatments" that ranged in substance and even theoretical efficacy. The role of estrogen was first accurately described in Guinea pigs in 1917 by Dr. Papanicolaou. AIM: To tell the detailed history of how estrogen was discovered and the controversy surrounding MHT.
METHODS: A literature search was conducted using PubMed to identify relevant studies and historical documents regarding the history of estrogen therapy.
RESULTS: The history of estrogen supplementation and its controversies are interesting stories and relevant to today's ongoing investigation into hormone replacement.
CONCLUSION: The controversy of MHT remained until the first randomized trials examining MHT in the early 1990s that suggested MHT is cardioprotective in postmenopausal women, although this conclusion was contradicted in subsequent trials. In the present day, MHT is approved only for short-term use for the symptomatic treatment of menopause. Kohn GE, Rodriguez KM, Hotaling J, et al. The History of Estrogen Therapy. Sex Med Rev 2019;7:416-421.
Copyright © 2019 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast Cancer; Estrogen; Hormone Replacement Therapy

Mesh:

Substances:

Year:  2019        PMID: 31147294      PMCID: PMC7334883          DOI: 10.1016/j.sxmr.2019.03.006

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  25 in total

1.  George Papanicolaou (1883-1962): Discoverer of the Pap smear.

Authors:  Siang Yong Tan; Yvonne Tatsumura
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

2.  Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.

Authors:  Marcia L Stefanick
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

3.  Landmark article Sept 8, 1923. An ovarian hormone. Preliminary report on its localization, extraction and partial purification, and action in test animals. By Edgar Allen and Edward A. Doisy.

Authors:  E Allen; E A Doisy
Journal:  JAMA       Date:  1983-11-18       Impact factor: 56.272

Review 4.  National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.

Authors: 
Journal:  J Natl Cancer Inst Monogr       Date:  2001

5.  A historical perspective on menopause and menopausal age.

Authors:  Amarjeet Singh; Sukhwinder Kaur; Indarjit Walia
Journal:  Bull Indian Inst Hist Med Hyderabad       Date:  2002 Jul-Dec

6.  Hormone therapy prescribing patterns in the United States.

Authors:  Diana S M Buist; Katherine M Newton; Diana L Miglioretti; Kevin Beverly; Maureen T Connelly; Susan Andrade; Cynthia L Hartsfield; Feifei Wei; K Arnold Chan; Larry Kessler
Journal:  Obstet Gynecol       Date:  2004-11       Impact factor: 7.661

7.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

8.  Use of progestogen therapy.

Authors:  R D Gambrell
Journal:  Am J Obstet Gynecol       Date:  1987-05       Impact factor: 8.661

9.  Breast cancer risk in relation to the interval between menopause and starting hormone therapy.

Authors:  Valerie Beral; Gillian Reeves; Diana Bull; Jane Green
Journal:  J Natl Cancer Inst       Date:  2011-01-28       Impact factor: 13.506

10.  The 2017 hormone therapy position statement of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2017-07       Impact factor: 3.310

View more
  3 in total

1.  Body, metabolic and renal changes following cross-sex estrogen/progestogen therapy in a rodent model simulating its use by transwomen.

Authors:  J V Gusmão-Silva; D C K Lichtenecker; L G A Ferreira; Í Gois; R Argeri; G N Gomes; M R Dias-da-Silva
Journal:  J Endocrinol Invest       Date:  2022-06-11       Impact factor: 5.467

2.  Aromatase Inhibition Eliminates Sexual Receptivity Without Enhancing Weight Gain in Ovariectomized Marmoset Monkeys.

Authors:  Marissa Kraynak; Molly M Willging; Alex L Kuehlmann; Amita A Kapoor; Matthew T Flowers; Ricki J Colman; Jon E Levine; David H Abbott
Journal:  J Endocr Soc       Date:  2022-04-22

Review 3.  Sex-Gender Disparities in Cardiovascular Diseases: The Effects of Estrogen on eNOS, Lipid Profile, and NFATs During Catecholamine Stress.

Authors:  Marie Louise Ndzie Noah; Gabriel Komla Adzika; Richard Mprah; Adebayo Oluwafemi Adekunle; Joseph Adu-Amankwaah; Hong Sun
Journal:  Front Cardiovasc Med       Date:  2021-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.